N-Acetylcysteine Attenuates Aβ-Mediated Oxidative Stress, Blood–Brain Barrier Leakage, and Renal Dysfunction in 5xFAD Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094352 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Atcharaporn Ontawong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY 40536, USA. Hauptthemen laut MEDLINE: Oxidative Stress, Blood-Brain Barrier, Acetylcysteine, Amyloid beta-Peptides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is characterized by amyloid-beta (Aβ) pathology and is closely linked to oxidative stress, which contributes to blood–brain barrier leakage, renal dysfunction, and cognitive decline. We investigated the effects of N-acetyl cysteine (NAC), an FDA-approved antioxidant, on oxidative stress, brain Aβ levels, barrier leakage, renal function, and cognition in 5xFAD mice. Eight-week-old 5xFAD mice were fed a rodent diet supplemented with 600 mg/kgDiet NAC for 4 weeks; wild-type (WT) mice and control 5xFAD mice were fed a regular rodent diet. We detected elevated brain and renal 4-hydroxynonenal(4-HNE) levels, reduced creatinine clearance, and increased plasma S100β levels in untreated 5xFAD mice compared to WT controls. Untreated 5xFAD mice also had higher capillary leakage, reduced P-gp activity, and impaired cognition compared to WT. NAC treatment of 5xFAD mice reduced brain Aβ40 levels, normalized 4-HNE levels to control levels, improved creatinine clearance, decreased capillary leakage, and lowered S100β plasma levels. NAC improved cognitive performance in 5xFAD mice, as shown by Y-maze. Our findings indicate that Aβ-induced oxidative stress contributes to barrier dysfunction, renal impairment, and cognitive deficits in 5xFAD mice. Notably, NAC treatment mitigates these effects, suggesting its potential as an adjunct therapy for AD and other Aβ-related pathologies by reducing oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sanders-Brown Center on Aging, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
- Division of Physiology, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
- Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY 40536, USA.
ORCID-Profile: Geetika Nehra, Bryan J Maloney, Chutima S Vaddhanaphuti, Björn Bauer
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- NIH HHS
- National Institute of Health
- Research and Researchers for Industry Grant
Zitieren
APA
Ontawong, A., Nehra, G., Maloney, B. J., Vaddhanaphuti, C. S., Bauer, B., & Hartz, A. M. S. (2025). N-Acetylcysteine Attenuates Aβ-Mediated Oxidative Stress, Blood–Brain Barrier Leakage, and Renal Dysfunction in 5xFAD Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094352
Vancouver
Ontawong A, Nehra G, Maloney BJ, Vaddhanaphuti CS, Bauer B, Hartz AMS. N-Acetylcysteine Attenuates Aβ-Mediated Oxidative Stress, Blood–Brain Barrier Leakage, and Renal Dysfunction in 5xFAD Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094352
BibTeX
@article{Ontawong2025,
author = {Ontawong, Atcharaporn and Nehra, Geetika and Maloney, Bryan J and Vaddhanaphuti, Chutima S and Bauer, Björn and Hartz, Anika M S},
title = {N-Acetylcysteine Attenuates Aβ-Mediated Oxidative Stress, Blood–Brain Barrier Leakage, and Renal Dysfunction in 5xFAD Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094352}
}
EUVIMED